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Development of renin 
expression
Renin appears during kidney develop-
ment in a complex manner, beginning 
ﬁrst in large arteries, then slowly local-
izing to smaller and smaller branches. In 
this issue, Sauter et al. describe the three-
dimensional pattern of expression of 
renin during mouse nephrogenesis. They 
find that as the kidney enlarges after 
birth, the branching of its arterial tree 
increases exponentially. Simultaneously, 
renin becomes restricted to the more 
distal parts of the tree. Eventually renin 
becomes restricted to the juxtaglomeru-
lar regions of aﬀerent arterioles. These 
arterioles express renin and α-smooth 
muscle actin. But as the kidney matures, 
only the terminal cells express renin. 
These results shed an interesting light on 
an issue that had been long discussed. 
In chronic renal artery stenosis, first 
increased expression of renin occurs. 
Then the renin-expressing cells slowly 
increase in number, eventually extending 
into the arcuate arteries. These patholog-
ical changes are remarkably similiar to 
those found in the developmental stud-
ies of Sauter et al., suggesting that the 
arcuate arteries and their branches might 
retain the capacity to express renin if the 
stimulus appears. See page 43.
Rituximab in 
membranous 
nephropathy
The treatment of membranous nephropa-
thy is disappointingly poor and has been 
a subject of numerous studies. The ﬁnd-
ing that B cells might be involved in its 
pathogenesis has suggested a new avenue 
for treatment. Rituximab, a monoclonal 
antibody, binds to the CD20 antigen on 
B cells, thereby deleting them. In a new 
study, Fervenza et al. treated 15 severely 
nephrotic patients with two doses of the 
antibody. Six months later, patients who 
remained proteinuric were treated again. 
Their levels of proteinuria were reduced to 
almost half of the original levels one year 
after initiation of therapy. Although full 
remission was seen in only two patients, 
partial remission was found in six patients. 
Only minor side effects occurred with 
treatment. These promising results show 
the need for more extensive trials in treat-
ing this diﬃcult disease. See page 117.
The kidney’s response 
to metabolic acidosis
The kidney’s response to metabolic aci-
dosis is a complex one involving many 
acute and chronic processes that aﬀect 
the acid–base transporters. However, the 
process that is important in whole-body 
physiology is the increase in net acid 
excretion; this occurs via an increase in 
the excretion of ammonia in the form of 
ammonium ions. Although it has been 
known that acidosis increases ammonia 
production in the kidney, largely because 
of increased expression of the rate-limiting 
enzyme, very little was known about the 
molecular mechanism of this process. 
The reason may be that one assumes the 
enzyme is induced, and one has to look 
for the correct transcription factor that 
acidosis activates. Ibrahim et al. reviewed 
extensive recent work on the mechanism 
of increased expression of glutaminase 
enzymes. Studies show that much of the 
kidney’s response to metabolic acidosis is 
mediated by selective stabilization of the 
mRNAs that encode the responsive pro-
teins. Remarkably, the mRNA contains a 
pH response element that is both neces-
sary and suﬃcient to impart a pH-respon-
sive stabilization to chimeric mRNAs. 
The literature also showed that acidosis 
initiates an endoplasmic reticulum stress 
response that leads to the formation of 
cytoplasmic stress granules. These results 
suggest the beginning of a solution to 
an ancient puzzle: how small changes in 
pH lead to large changes in enzyme syn-
thesis that mediate an essential adaptive 
response by the kidney. See page 11.
